Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Symphony Limited Earnings Release 2026

Aug 1, 2025

60717_rns_2025-08-01_02092788-a573-4ae6-a951-41edbb8e22e8.pdf

Earnings Release

Open in viewer

Opens in your device viewer

August 01, 2025

==> picture [567 x 32] intentionally omitted <==

To, National Stock Exchange of India Limited Symbol – Symphony

To, BSE Limited Security Code – 517385

Sub.: Media Release

Dear Sir / Madam,

This is in reference to the above captioned subject line and in continuation with our today’s announcement, we are enclosing herewith media release titled “Media Release (Jun’25 Qtr. Result)”.

Kindly consider this in due Compliance of Regulation 30 and other applicable provisions, if any of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Kindly take note of the same and oblige.

Thanking you,

Yours Truly, For, Symphony Limited MAYUR C. Digitally signed by MAYUR C. BARVADIY BARVADIYA Date: 2025.08.01 A 11:52:08 +05'30' Mayur Barvadiya Company Secretary and Head - Legal

Encl: as above

Registered Office: Symphony Limited, “Symphony House”, Third Floor, FP-12, TP-50, Off S.G. Highway, Bodakdev, Ahmedabad -380 059, India T: +91-79-66211111, F: +91-79-66211139-40 l Email – [email protected] I www.symphonylimited.com CIN - L32201GJ1988PLC010331

==> picture [81 x 34] intentionally omitted <==

Media Release (Jun’25 Qtr. Result) Financial Highlights:

(₹ Crores)
Standalone Consolidated
Particulars Jun’25
Qtr.
Jun’24
Qtr.
Growth
(%)
Jun’25
Qtr.
Jun’24
Qtr.
Growth
(%)
Revenue from Operations 229 373 (-39%) 251 393 (-36%)
EBITDA 24 82 (-71%) 26 88 (-71%)
EBITDA Margin (%) 10.3% 22.0% (-11.7%) 10.2% 22.3% (-12.1%)
PAT 37 69 (-46%) 42* 88* (-52%)

*Includes PAT from (i) continuing operations (Symphony India, GSK China, SCL Brazil) and (ii) discontinued operations (IMPCO Mexico, Symphony AU Australia) in accordance with Ind AS, net of inter-company transaction.

The Board of Directors of the Company in its today’s meeting has approved an interim dividend of ₹1 per share (Face Value: ₹2/-) for FY 25-26.

August 01, 2025: Mr. Nrupesh Shah, Managing Director (Corporate Affairs), Symphony Limited has commented:

Symphony Limited today announced its financial results for the quarter ending June 2025, reporting a 39% year-on-year decline in standalone revenue. This is primarily attributed to pronounced seasonal headwinds, further accentuated by a high base of the June 2024 quarter.

  • Symphony delivered its second-highest June quarter (summer-season) standalone revenue on record and surpassed earlier second-best summer season, despite a shortened and rain-impacted summer-25, coupled with the early onset of monsoon.

  • Standalone EBITDA margin declined by 11.7%, primarily due to product mix and YoY reduced operating leverage.

  • GSK China continued its robust growth momentum, making strides towards becoming debt-free. During FY26 yearto-date, GSK China repaid ₹27.9 crore towards its inter-company loan to Symphony India, reducing outstanding loan to ₹26.1 crore from a peak of ₹59.8 crore in May 2024. The trajectory is bolstered by intellectual property rights monetization and internal cash generation.

  • IMPCO Mexico experienced subdued performance attributed to a milder summer, which moderated EBITDA margins due to YoY lower operating leverage.

  • Symphony AU Australia posted its second consecutive quarter of year-on-year growth, driven by ongoing business transformation initiatives. Key levers fueling this momentum include an asset-light operating model, strategic product and market expansion, accelerated sales, and cost optimization.

  • GSK China has successfully transferred technology know-how and nine intellectual property rights (IPRs) to IMPCO Mexico. The total transaction is valued at ~ ₹44 crore, with the first tranche, amounting to around ₹22 crore, already completed. The remaining balance is scheduled for completion in the September 2025 quarter. This move not only

==> picture [531 x 73] intentionally omitted <==

==> picture [81 x 34] intentionally omitted <==

accelerates IMPCO Mexico’s product-led growth but also enhances prospects for IMPCO’s divestment / monetization. GSK China continues to retain a strong portfolio of products and IPRs, ensuring sustained innovation and future growth.

Strategic Outlook and Way Forward

  • Building on our commitment to innovation and market leadership, Symphony Limited is strategically revolutionizing the largely unorganized air cooler sector with the introduction of the ‘Air Force’ range. In response to strong market traction, we are accelerating efforts to scale up this product line, further cementing its leadership in the category.

  • We are advancing growth across all-season and counter-seasonal product categories—including tower and kitchen cooling fans, large-space venti-cooling (LSV), and water heaters—by harnessing innovation, brand and distribution excellence.

  • Our robust distribution network and best-in-class after-sales service underpin customer loyalty and reinforce our market leadership. Strategic focus on semi-urban and rural markets, coupled with accelerated digital and modern trade expansion, unlocks long-term growth potential.

  • Internationally, we are sharpening our strategic focus to concentrate on high-growth and high-margin markets— especially India and select export markets (through export-led model).

ABOUT SYMPONY LIMITED:

Symphony Limited, an Indian Multi-National Company with presence in over 60 countries, is the world’s leading air cooler company. From inventions to innovations, energy responsibility to environment stewardship, Symphony is a market leader which has been providing comfort cooling to its customers for generations. The massive supremacy of Symphony coolers in the residential, industrial and commercial segments has made the brand synonymous with ‘air-cooling’.

Founded in 1988 in Gujarat, India, Symphony Limited pioneered the evaporative air-cooling category in the country and scaled it globally. As a disruptor in a largely unorganized market, Symphony redefined industry standards, setting the benchmark for innovation, energy efficiency, and design excellence.

The Company’s sustained competitive edge stems from a strong focus on R&D and innovation, enabling the launch of market-leading, customer-centric products. Symphony is now accelerating growth across all-season and counter-seasonal categories—including tower and kitchen cooling fans, large space venti-cooling (LSV), and water heaters—by leveraging its innovation engine, powerful brand equity, and robust distribution network.

==> picture [531 x 73] intentionally omitted <==

***